US 10676475
Compounds for improving mRNA splicing
granted A61PA61P25/28
Quick answer
US patent 10676475 (Compounds for improving mRNA splicing) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P25/28